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Hemodynamic changes in 
infective endocarditis
ABSTRACT
Hemodynamic disturbances in patients with infective endocarditis (IE) are complex and might be consequences of various 
pathogenic processes. Congestive heart failure (CHF) is a major contributor of hemodynamic derangements, but since IE 
is often a septic disease, reversible myocardial dysfunction as well as septic shock might sometimes dominate or repre-
sent additional contributing factors of disturbed hemodynamics. The major cause of CHF is malfunction of affected valves. 
It occurs with an incidence of 32 % and is often severe. This is why CHF is the most important risk factor associated with 
poor patient outcome. Results of the project 'International Collaboration on Endocarditis’ related to the characteristics of 
CHF in patients with IE are presented.
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Infective endocarditis (IE) is still a seri-
ous disease with a high mortality (16 
– 20%) overall. It is a localized infec-
tion involving the heart valves in the 
majority of patients, but it is also often 
a generalized infection associated with 
the systemic inflammatory response 
syndrome and numerous septic metas-
tases in various parts of the body. Due 
to this, there is a diversity of pathogenic 
mechanisms involved in the hemody-
namic changes in IE.
The clinical and microbiological spectra 
of IE have been evolving continually from 
the first descriptions of the disease at 
the beginning of the 20th century. The 
changing profile of IE is nowadays well 
established and documented (table 1). 
(1-3) 
During the first seventy years of the 
twentieth century IE was usually of a 
subacute clinical course because less 
pathogenic bacteria, like alpha-hemo-
lytic streptococci of the viridans group, 
dominated as major pathogens. They 
did not induce a pronounced inflam-
matory response. Rheumatic valve dis-
ease was the major underlying cause. 
Nowadays, the course of IE is mostly 
acute, septic and the most common 
pathogen is Staphylococcus aureus. 
The incidence of enterococcal or Strep-
tococcus bovis infections has risen. 
Atherosclerotic valvular disease is the 
most common form of valvular dis-
ease due to the increased incidence 
of degenerative valvular lesions asso-
ciated with an ageing population. IE 
occurs in patients without previously 
known cardiac disease in up to almost 
50% of patients. The average age of 
patients with IE has increased over time 
resulting in a shift towards the eighth or 
even ninth decade of life. Other more 
prevalent risk factors associated with 
IE, are patients with implanted intrac-
ardiac devices (pacemakers, defibril-
lators) although, fortunately, there is a 
decreased incidence in patients with 
prosthetic valve infective endocarditis 
(PVIE). A horrific increase in the number 
of intravenous drug addicts has led to a 
greater incidence of right-sided IE.
Recently, some other epidemiological 
characteristics of IE have emerged. 
Although community-acquired infec-
tions still dominate, health care associ-
ated infections are growing, particularly 
those associated with dialysis, implan-
tation of Hickman’s and Broviac cathe-
ters and other invasive procedures. (4)
All these changes affect the hemody-
namics in patients with IE in regard to its 
pathogenesis and incidence (figure 1).
While hemodynamic derangements 
associated with valvular or paravalvular 
dysfunctions are well known, changes 
• Increasing average age
• Lower number of patients with previously recognized valve disease
• Decrease in the incidence of PVIE
• Increase in the incidence of S. Aureus and BHS ´D´ infections
• Health care associated IE increased
• IE in iv. addicts increased
• Earlier cardiac surgery
• Better prognosis
Table 1. Changing aspects of IE.
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associated with systemic inflamma-
tory response syndrome (SIRS) and 
organ dysfunctions are not adequately 
addressed in clinical research of IE.  It 
is often forgotten that IE is only one seg-
ment of a generalized, acute systemic 
inflammatory response – sepsis. 
The most established hemodynamic 
changes are associated with infections 
of valves and surrounding tissues and 
consequent valve dysfunction. The most 
important and most severe complica-
tion is congestive heart failure (CHF) 
which may rapidly progress due to the 
dysfunction of heart valves (rapid pro-
gression of aortic and/or mitral regur-
gitation), valve perforation, formation of 
a paravalvular abscess and fistulation, 
paravalvular leak due to dehiscence of 
prosthetic valves (table 2). Congestive 
heart failure demands earlier surgical 
intervention, which is one of the most 
important factors today contributing to 
a better prognosis.
CHF, along with embolizations, is the 
most common complication of IE. The 
incidence of CHF in patients with IE is 
30% to 40%. Despite this, CHF has not 
been particularly evaluated in sepa-
rate studies because it is a well-known 
complication with few unresolved ques-
tions. Our center in the Hospital for 
Infectious Diseases is actively involved 
in a project known as the 'International 
Collaboration on Endocarditis Prospec-
tive Surveillance’. A global database 
has been formed which includes over 
5000 patients from all continents. The 
center of the project is at Duke Uni-
versity. I will present here an analysis 
of the incidence and characteristics of 
patients with CHF. There have been, up 
until now, 2787 patients with definite IE 
according to Duke criteria. The mean 
age is 56+-18 years; males dominate 
(68%). CHF occurred in 877 (32%) 
of patients. The severity of CHF was 
reported in 761 patients (193 missing 
values) according to NYHA classifi-
cation (figure 2). These data suggest 
that CHF is a severe, life threatening 
complication in the majority of patients 
in whom it occurred. However, it is not 
easy to interpret these data because 
often patients with IE are septic and 
symptoms of sepsis overlap symptoms 
and signs of CHF.
Does CHF occur more often in eld-
erly patients? Despite a slight tenden-
cy towards a greater incidence in the 
group of patients older than 74 years, 
the difference was not statistically sig-
nificant (figure 3). This is in accordance 
with other ICE reports.
One might expect that because of a 
worse prognosis for patients with PVIE, 
the incidence of CHF is higher com-
pared to native valve disease. We were 
not able to confirm this. The incidence 
of CHF was 621 out of 1906 (32.6%) 
patients with NVIE and 175 out of 564 
(31%) patients with PVIE.
Is localization of IE associated with 
CHF? Sexton and al. showed that aortic 
valve disease is more commonly associ-
ated with CHF than mitral valve involve-
ment (28% vs. 20%). (5) In our group 
of patients with left-sided NVIE the inci-
dence of CHF was significantly higher if 
both valves were affected (53.7%) than 
if only the aortic valve (37.5%) or mitral 
valve (31.1%) were involved.
Since S. aureus is the most common 
pathogen causing IE today with a worse 
prognosis than IE caused by other 
bacteria, we asked if S. aureus IE was 
associated with a greater incidence of 
CHF. Interestingly, there was a signifi-
cant increase in the incidence of CHF 
among patients with staphylococcal 
NVIE (34.1% vs. 29.4%, p=0.04). That 
was not observed in PVIE (figure 4). 
There was no difference in the inci-
dence of CHF in patients with IE caused 
with MSSA compared to MRSA.
Patients with CHF were more common-
ly subjected to cardiac surgery than 
patients without CHF (62% vs. 38.9%, 









Table 2. Hemodynamic derangements in patients with IE.
Changes associated with sepsis
• Hyperdynamic phase
• Reversible myocardial dysfunction
• Septic shock




Other focuses of infection
Etiology
Characteristics of local lesions
Localisation, complications
Characteristics of vegetation




• Chronic diseases of valves
and other diseases
• Foreign materials
Intensisty of the systemic 




p<0.05 in patients with PVIE). Cardiac 
surgery, in a number of studies, has 
been associated with better patient sur-
vival and CHF is often the commonest 
indication for surgery. 
Intra-hospital mortality was significant-
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Figure 3. Influence of age on the incidence of congestive heart failure in 
patients with infective endocarditis (ICE study).
Figure 2. Severity of congestive 
heart failure (CHF) according to 
NYHA classification in patients with 
infective endocarditis (ICE study).
ly higher amongst patients with CHF 
(27.5% vs. 11.1% in NVIE and 33.5% 
vs. 18.3% in PVIE). Other ICE studies 
confirmed that CHF is the most impor-
tant independent factor associated with 
intra-hospital death in patients with IE.
These data explain why hemodynamic 
complications are, along with central-
nervous system embolizations, the 
most important factor that necessitates 
admission of patients with IE to inten-
sive care units (ICU). The incidence of 
CHF in patients admitted to ICU is 28% 
to 64%. (6,7) 
Because of the striking evidence of the 
association between CHF and poor 
patient survival, other aspects of hemo-
dynamic derangement have been less 
evaluated. It is often forgotten that IE 
is in the majority of patients a septic 
disease. Changes in peripheral vas-
cular resistance, cardiac output and 
blood pressure add to derangements 
associated with valve failure. Revers-
Figure 4. Congestive heart failure 
in patients with staphylococcal 
endocarditis (ICE study).
ible myocardial dysfunction is further 
imposed on existing disturbances and 
should be taken into consideration in 
patients with IE. Severe CHF is associ-
ated with pulmonary edema, which is 
further complicated by ARDS and capil-
lary leak syndrome, which accompany 
severe sepsis and septic shock. Central 
nervous system complications might 
be further complicated by neurogenic 
shock and renal failure with volume 
overload. All these hemodynamic con-
sequences of IE are often superim-
posed on chronic cardiac diseases, 
particularly in elderly patients.
The complexity of hemodynamic 
changes in patients with IE is also 
reflected in therapeutic options in sep-
tic patients. It is clear how treatment 
with fluids and sympatomymetics must 
be well balanced as well as invasive 
organ support such as mechanical 
ventilation and applied renal replace-
ment therapy. 
However, many problems still remain 
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